Clinical Trial Update: Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient [Phase 1]

View source ↗

Summary

A Phase 1 safety and tolerability study of AZD4547 in Japanese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AZD4547

Snippet

Sponsor: AstraZeneca | Conditions: Cancer, Advanced Solid Malignancies | Phase 1 | Status: COMPLETED